Company Profile
Updated: 28-OCT-09Madaus S.A.
Non-Quoted Public Company
Foc 68-82, Barcelona, E-08038, Spain
()34 93 298 82 00, 34 93 223 16 52 fax, http://www.madaus.es
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture, sale and export of pharmaceuticals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Millipore Corporation named Corporate Citizen of the Year.
Business Wire; 11/12/2009; 1505 words; ...Council. The company's commitment to reducing...President and CEO Martin Madaus, along with Director of...award at the Council's Green Tie Gala held last...accelerating the region's clean energy economy...Energy Council," said Madaus. "We firmly believe that...
Millipore Posts 3Q 2009 Financial Results.(Financial report)
Health & Beauty Close-Up; 11/10/2009; 985 words; ...percent, while the Company's Bioscience Division generated...the previous year. Millipore's third quarter earnings per share...is provided in the Company's financial tables accompanying...throughout 2009," said Martin Madaus, Chairman & CEO of Millipore...
Indevus Files NDA On Trospium For Treating Overactive Bladder.
BIOWORLD Today; 11/4/2009; 1099 words; ...contractions. Indevus licensed the U.S. rights to the product from Madaus AG, of Koln, Germany, in 1999...overactive bladder market in the U.S. is estimated to be near $1 billion annually and growing, but it's a market characterized by dissatisfaction...
Indevus' Trospium Phase III Hits Primary, Secondary Endpoints.
BIOWORLD Today; 11/4/2009; 1074 words; ...trospium trial took place at 50 U.S. sites and involved 523 patients...Europe - Indevus licensed the U.S. rights to the product from Madaus AG, of Koln, Germany, in 1999...trospium is unpartnered in the U.S., but Indevus is examining its...
Pfizer Gives Pagoclone Back To Indevus; Stock Plummets.
BIOWORLD Today; 11/4/2009; 1290 words; ...important valuation drug," the U.S. marketing rights for which were acquired from Germany-based Madaus AG in November 1999. Interneuron is responsible for all U.S. clinical development and will...milestone and royalty payments to Madaus. Enrollment is almost done for...
Recent News Articles
- Martin Madaus Joins Mettler Toledo Board of Directors.
Biotech Week - July 08, 2009 - Martin Madaus Joins Mettler Toledo Board of Directors.
PR Newswire - June 22, 2009 - Predictive Biosciences Appoints Martin Madaus, Millipore CEO and Chairman, to Board of Directors.
Business Wire - January 31, 2008 - Rottapharm makes biggest Italian pharma acquisition, buying Madaus.(Rotta Farmaceutici S.p.A.)
Pharma Marketletter - June 25, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning